drugset / Trial / NCT06698926
A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants
RandomizedParallel-groupTriple-blindBasic science
Summary
This is a Phase 1, first in human, randomized, four-part study to investigate the safety, tolerability, and pharmacokinetics of ABBV-CLS-616 after oral dosing in healthy volunteers.
Timeline
- Start
- 2024-11-11
- Primary completion
- 2026-01-09
- Completion
- 2026-01-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-CLS-616 | Unknown | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
Indications
No indication recorded.